Trials / Completed
CompletedNCT02169401
A Multi-centre Observational Study of the Axium Neurostimulator as a Treatment for Chronic Pain
a PRospEctive Post Market Trial of Drg stImulation With the Commercially Available Axium
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 135 (actual)
- Sponsor
- Abbott Medical Devices · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
08-SMI-2012 is a post market, observational, questionnaire based study to assess the effectiveness of the commercially available Axium neurostimulator in the management of intractable, chronic pain.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Implantation with the commercially available Axium Neurostimulator |
Timeline
- Start date
- 2012-11-01
- Primary completion
- 2017-01-25
- Completion
- 2017-01-25
- First posted
- 2014-06-23
- Last updated
- 2024-11-14
- Results posted
- 2024-11-14
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT02169401. Inclusion in this directory is not an endorsement.